Lv2
118 积分 2024-05-15 加入
The global burden of inflammatory bowel disease: from 2025 to 2045
8天前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
8天前
已完结
Cellular retinol-binding protein 1: a therapeutic and diagnostic tumor marker
15天前
已完结
Inflammatory Bowel Disease
1个月前
已完结
The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care
1个月前
已完结
Neutrophils: from IBD to the gut microbiota
1个月前
已完结
Oral Infigratinib Therapy in Children with Achondroplasia
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
3个月前
已完结
Inhibition of KAT6A enhances immunotherapy efficacy in colorectal cancer by activating interferon response
3个月前
已完结
Identification of triazolyl KAT6 inhibitors via a templated fragment approach
3个月前
已完结
皖公网安备34019202002308
